Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.4K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

808
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
808
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

3.0K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
3.0K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

501
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
501
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

537
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
537
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

413
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered neurodevelopmental trajectories of brain structure in Tourette syndrome and Chronic Tic Disorders.

medRxiv : the preprint server for health sciences·2026
Same author

Developmental delay in attaining adult levels of motor excitability in children and adolescents with Tourette syndrome: a mega-analysis study.

bioRxiv : the preprint server for biology·2026
Same author

Doxycycline, Schizophrenia, and Toxoplasmosis.

The American journal of psychiatry·2026
Same author

Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome.

Movement disorders clinical practice·2025
Same author

Tourette syndrome research highlights from 2024.

F1000Research·2025
Same author

Correlating clinical course with baseline subcortical shape in provisional tic disorder.

CNS spectrums·2024
Same journal

The Outcome of Cardiac Hydatid Surgery in The Iraqi Center of Heart Diseases.

F1000Research·2026
Same journal

Perception of body donation among the Phase-1 medical students, a questionnaire-based study.

F1000Research·2026
Same journal

Exploring Infertility in Saudi Arabia: Qualitative Insights into IVF Treatment Services and Policy Recommendations.

F1000Research·2026
Same journal

Cyber Military Operations under International Humanitarian Law: Interpreting the Concept of "Attack" and Challenges in Protecting Civilians.

F1000Research·2026
Same journal

Sentiment Analysis of Acceptance TVET Online Courses on the Skill Academy App from Google Play: Leveraging Text Mining with Comparison Machine Learning Model.

F1000Research·2026
Same journal

Emotional intelligence: An important skill to learn now more than ever.

F1000Research·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

79.7K

Optimal timing for lithium levels.

Kevin J Black1

  • 1Departments of Psychiatry, Neurology, Radiology, and Neuroscience, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA.

F1000Research
|January 29, 2025
PubMed
Summary
This summary is machine-generated.

For extended-release lithium, draw blood 12 hours after the last dose. This timing allows accurate comparison with standard immediate-release lithium levels, ensuring consistent patient monitoring.

Keywords:
administration & dosageblood levelconcentrationlithiumpharmacokineticspharmacology

More Related Videos

In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries
11:25

In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries

Published on: November 10, 2014

15.7K
Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries
10:41

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries

Published on: May 22, 2018

36.6K

Related Experiment Videos

Last Updated: May 6, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

79.7K
In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries
11:25

In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries

Published on: November 10, 2014

15.7K
Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries
10:41

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries

Published on: May 22, 2018

36.6K

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Psychiatric Medication Management

Background:

  • Current guidelines suggest varying blood draw times for lithium levels.
  • Extended-release (ER) lithium formulations aim to reduce peak serum concentrations.
  • Accurate therapeutic drug monitoring is crucial for lithium efficacy and safety.

Purpose of the Study:

  • To determine the optimal blood draw timing for ER lithium formulations.
  • To establish a consistent method for comparing ER lithium levels with historical data.
  • To address discrepancies in interpreting ER lithium levels versus immediate-release formulations.

Main Methods:

  • Analysis of published pharmacokinetic data for ER lithium formulations.
  • Comparison of serum lithium concentrations between immediate-release and ER formulations at various time points.
  • Interpretation of absorption and excretion profiles of ER lithium.

Main Results:

  • Extended-release lithium formulations are fully absorbed within 8 hours of dosing.
  • Lithium levels in ER formulations are comparable to immediate-release formulations at 12 hours post-dose.
  • Peak serum concentrations are reduced with ER formulations, but elimination is not significantly altered.

Conclusions:

  • The ideal time for blood draws with once-daily ER lithium is 12 hours after the previous dose.
  • This 12-hour timing facilitates direct comparison with established therapeutic ranges derived from immediate-release lithium.
  • Accurate comparison ensures effective therapeutic drug monitoring and patient management.